R. Spector and C. Johanson, The Mammalian Choroid Plexus, Scientific American, vol.261, issue.5
DOI : 10.1038/scientificamerican1189-68

H. Hemsley and D. Crook, Encyclopedia of Life Sciences, 2001.

R. E. Banks, A. J. Stanley, D. A. Cairns, and J. H. Barrett, Influences of Blood Sample Processing on Low-Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry, Clinical Chemistry, vol.51, issue.9, pp.1637-1649, 2005.
DOI : 10.1373/clinchem.2005.051417

K. S. Shores and D. R. Knapp, Assessment Approach for Evaluating High Abundance Protein Depletion Methods for Cerebrospinal Fluid (CSF) Proteomic Analysis, Journal of Proteome Research, vol.6, issue.9, pp.3739-3751, 2007.
DOI : 10.1021/pr070293w

A. F. Huhmer, R. G. Biringer, H. Amato, A. N. Fonteh, and M. G. Harrington, Protein Analysis in Human Cerebrospinal Fluid: Physiological Aspects, Current Progress and Future Challenges, Disease Markers, vol.22, issue.1-2, pp.3-26, 2006.
DOI : 10.1155/2006/158797

Y. Ogata, M. C. Charlesworth, and D. C. Muddiman, Evaluation of Protein Depletion Methods for the Analysis of Total-, Phospho- and Glycoproteins in Lumbar Cerebrospinal Fluid, Journal of Proteome Research, vol.4, issue.3, pp.837-845, 2005.
DOI : 10.1021/pr049750o

B. Dubois, H. H. Feldman, C. Jacova, and S. T. Dekosky, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-746, 2007.
DOI : 10.1016/S1474-4422(07)70178-3

K. Blennow and H. Hampel, CSF markers for incipient Alzheimer's disease, The Lancet Neurology, vol.2, issue.10, pp.605-613, 2003.
DOI : 10.1016/S1474-4422(03)00530-1

B. Ibach, H. Binder, M. Dragon, and S. Poljansky, Cerebrospinal fluid tau and ??-amyloid in Alzheimer patients, disease controls and an age-matched random sample, Neurobiology of Aging, vol.27, issue.9, pp.1202-1211, 2006.
DOI : 10.1016/j.neurobiolaging.2005.06.005

S. K. Herukka, S. Helisalmi, M. Hallikainen, and S. Tervo, CSF A??42, Tau and phosphorylated Tau, APOE ??4 allele and MCI type in progressive MCI, Neurobiology of Aging, vol.28, issue.4, pp.507-514, 2007.
DOI : 10.1016/j.neurobiolaging.2006.02.001

M. G. Harrington, C. R. Merril, D. M. Asher, and D. C. Gajdusek, Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt???Jakob Disease, New England Journal of Medicine, vol.315, issue.5, pp.315-279, 1986.
DOI : 10.1056/NEJM198607313150502

I. Zerr, M. Bodemer, M. Otto, and S. Poser, Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid, The Lancet, vol.348, issue.9031, pp.846-849, 1996.
DOI : 10.1016/S0140-6736(96)08077-4

G. Hsich, K. Kenney, C. J. Gibbs, K. H. Lee, and M. G. Harrington, The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies, New England Journal of Medicine, vol.335, issue.13, pp.924-930, 1996.
DOI : 10.1056/NEJM199609263351303

M. Reindl, C. Linington, U. Brehm, and R. Egg, Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study, Brain, vol.122, issue.11, pp.2047-2056, 1999.
DOI : 10.1093/brain/122.11.2047

T. Berger, P. Rubner, F. Schautzer, and R. Egg, Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event, New England Journal of Medicine, vol.349, issue.2, pp.139-145, 2003.
DOI : 10.1056/NEJMoa022328

E. J. Thompson, Proteins of the Cerebrospinal Fluid, pp.13-31, 2005.

S. Lovestone, A. Guntert, A. Hye, and S. Lynham, Proteomics of Alzheimer???s disease: understanding mechanisms and seeking biomarkers, Expert Review of Proteomics, vol.293, issue.2, pp.227-238, 2007.
DOI : 10.1006/bbrc.2002.6678

D. E. Terry and D. M. Desiderio, Between-gel reproducibility of the human cerebrospinal fluid proteome, PROTEOMICS, vol.3, issue.10, pp.1962-1979, 2003.
DOI : 10.1002/pmic.200300463

Y. Hu, J. P. Malone, A. M. Fagan, R. R. Townsend, and D. M. Holtzman, Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid, Molecular & Cellular Proteomics, vol.9, issue.12, 2000.
DOI : 10.1002/ana.20009

X. Yuan and D. M. Desiderio, Human cerebrospinal fluid peptidomics, Journal of Mass Spectrometry, vol.308, issue.2, pp.176-181, 2005.
DOI : 10.2174/1386207013331246

X. Yuan and D. M. Desiderio, Proteomics analysis of human cerebrospinal fluid, Journal of Chromatography B, vol.815, issue.1-2, pp.179-189, 2005.
DOI : 10.1016/j.jchromb.2004.06.044

X. Yuan and D. M. Desiderio, Proteomics analysis of prefractionated human lumbar cerebrospinal fluid, PROTEOMICS, vol.271, issue.2, pp.541-550, 2005.
DOI : 10.1002/pmic.200400934

S. Pan, D. Zhu, J. F. Quinn, and E. R. Peskind, A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry, PROTEOMICS, vol.33, issue.3, pp.469-473, 2007.
DOI : 10.1155/2006/158797

M. Ramstrom, I. Ivonin, A. Johansson, and H. Askmark, Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry, PROTEOMICS, vol.53, issue.Suppl., pp.4010-4018, 2004.
DOI : 10.1016/S0022-510X(99)00019-2

E. R. Peskind, R. Riekse, J. F. Quinn, and J. Kaye, Safety and Acceptability of the Research Lumbar Puncture, Alzheimer Disease & Associated Disorders, vol.19, issue.4, pp.220-225, 2005.
DOI : 10.1097/01.wad.0000194014.43575.fd

G. Lippi, G. Banfi, M. Buttarello, and F. Ceriotti, Abstract, Clinical Chemical Laboratory Medicine, vol.67, issue.6, pp.728-736, 2007.
DOI : 10.1007/BF02982039

H. Vanderstichele, E. Van-kerschaver, C. Hesse, and P. Davidsson, in cerebrospinal fluid and plasma, Amyloid, vol.2, issue.4, pp.245-258, 2000.
DOI : 10.1038/sj.mp.4000313

S. Roche, L. Tiers, M. Provansal, M. T. Piva, and S. Lehmann, Interest of major serum protein removal for Surface- Enhanced Laser Desorption/Ionization ? Time Of Flight (SELDI-TOF) proteomic blood profiling, Proteome Sci, 1920.
URL : https://hal.archives-ouvertes.fr/hal-00113437

E. J. Finehout, Z. Franck, N. Relkin, and K. H. Lee, Proteomic Analysis of Cerebrospinal Fluid Changes Related to Postmortem Interval, Clinical Chemistry, vol.52, issue.10, pp.1906-1913, 2006.
DOI : 10.1373/clinchem.2006.070508

O. Carrette, I. Demalte, A. Scherl, and O. Yalkinoglu, A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease, PROTEOMICS, vol.3, issue.8, pp.1486-1494, 2003.
DOI : 10.1002/pmic.200300470

O. Carrette, P. R. Burkhard, S. Hughes, D. F. Hochstrasser, and J. C. Sanchez, Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process? Proteomics, pp.3060-3065, 2005.
DOI : 10.1002/pmic.200402039

R. J. Freilich, G. Krol, and L. M. Deangelis, Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis, Annals of Neurology, vol.13, issue.1, pp.51-57, 1995.
DOI : 10.1148/radiology.163.2.3562825

M. S. Lim and K. S. Elenitoba-johnson, Ubiquitin Ligases in Malignant Lymphoma, Leukemia & Lymphoma, vol.21, issue.7, pp.1329-1339, 2004.
DOI : 10.1093/emboj/cdg600

F. W. Khwaja, J. D. Nolen, S. E. Mendrinos, and M. M. Lewis, Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers, PROTEOMICS, vol.21, issue.23, pp.6277-6287, 2006.
DOI : 10.1007/BF02389687

F. W. Khwaja, J. S. Duke-cohan, D. J. Brat, and E. G. Van-meir, Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration, Clinical Cancer Research, vol.12, issue.21, pp.6331-6336, 2006.
DOI : 10.1158/1078-0432.CCR-06-1296

I. Zerr, M. Bodemer, O. Gefeller, and M. Otto, Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease, Annals of Neurology, vol.63, issue.1, pp.32-40, 1998.
DOI : 10.1212/WNL.47.5.1305

A. J. Green, E. J. Thompson, G. E. Stewart, and M. Zeidler, Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.70, issue.6, pp.744-748, 2001.
DOI : 10.1136/jnnp.70.6.744

K. J. Lamers, B. G. Van-engelen, F. J. Gabreels, and O. R. Hommes, Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders, Acta Neurologica Scandinavica, vol.22, issue.3, pp.247-251, 1995.
DOI : 10.1161/01.STR.22.10.1254

M. Ohta, K. Ohta, J. Ma, and J. Takeuchi, Clinical and analytical evaluation of an enzyme immunoassay for myelin basic protein in cerebrospinal fluid, Clin. Chem, vol.46, pp.1326-1330, 2000.

M. Markovic, V. Trajkovic, J. Drulovic, and S. Mesaros, Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients, Journal of the Neurological Sciences, vol.211, issue.1-2, pp.67-73, 2003.
DOI : 10.1016/S0022-510X(03)00066-2

B. G. Xiao, C. Linington, and H. Link, Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls, Journal of Neuroimmunology, vol.31, issue.2, pp.31-91, 1991.
DOI : 10.1016/0165-5728(91)90014-X

M. He, T. Ohrui, M. Maruyama, and N. Tomita, ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease, Neurology, vol.67, issue.7, pp.1309-1310, 2006.
DOI : 10.1212/01.wnl.0000238102.04582.ec

M. Puchades, S. F. Hansson, C. L. Nilsson, and N. Andreasen, Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease, Molecular Brain Research, vol.118, issue.1-2, pp.140-146, 2003.
DOI : 10.1016/j.molbrainres.2003.08.005

E. M. Castano, A. E. Roher, C. L. Esh, T. A. Kokjohn, and T. Beach, Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects, Neurological Research, vol.199, issue.2, pp.155-163, 2006.
DOI : 10.1038/labinvest.3780116

P. Davidsson, A. Westman-brinkmalm, C. L. Nilsson, and M. Lindbjer, Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients, Neuroreport, vol.13, issue.5, pp.611-615, 2002.
DOI : 10.1097/00001756-200204160-00015

E. J. Finehout, Z. Franck, L. H. Choe, N. Relkin, and K. H. Lee, Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease, Annals of Neurology, vol.20, issue.2, pp.61-120, 2007.
DOI : 10.1212/WNL.34.7.939

M. Sjogren, P. Davidsson, J. Gottfries, and H. Vanderstichele, The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer???s Disease, Reflecting a Common Pathophysiological Process, Dementia and Geriatric Cognitive Disorders, vol.12, issue.4, pp.257-264, 2001.
DOI : 10.1159/000051268

Z. Zhong, M. Ewers, S. Teipel, and K. Burger, Levels of ??-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment, Archives of General Psychiatry, vol.64, issue.6, pp.718-726, 2007.
DOI : 10.1001/archpsyc.64.6.718

J. C. Sanchez, E. Guillaume, P. Lescuyer, and L. Allard, Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease, PROTEOMICS, vol.4, issue.8, pp.2229-2233, 2004.
DOI : 10.1002/pmic.200300799

J. W. Lee, H. Namkoong, H. K. Kim, and S. Kim, Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease, BMC Neurology, vol.36, issue.12, 2007.
DOI : 10.1161/01.STR.0000189721.31432.26

M. Sjogren, L. Minthon, P. Davidsson, and A. K. Granerus, CSF levels of tau, beta-amyloid(1?42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging, J. Neural. Transm, vol.107, pp.563-579, 2000.

R. Fukuyama, T. Izumoto, and S. Fushiki, The Cerebrospinal Fluid Level of Glial Fibrillary Acidic Protein Is Increased in Cerebrospinal Fluid from Alzheimer???s Disease Patients and Correlates with Severity of Dementia, European Neurology, vol.46, issue.1, pp.35-38, 2001.
DOI : 10.1159/000050753

A. Wallin, K. Blennow, and L. E. Rosengren, Glial Fibrillary Acidic Protein in the Cerebrospinal Fluid of Patients with Dementia, Dementia and Geriatric Cognitive Disorders, vol.7, issue.5, pp.267-272, 1996.
DOI : 10.1159/000106891

A. Merched, J. M. Serot, S. Visvikis, and D. Aguillon, Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry, FEBS Letters, vol.231, issue.2, pp.225-228, 1998.
DOI : 10.1006/bbrc.1997.6137

J. G. Sheng, R. E. Mrak, C. R. Rovnaghi, and E. Kozlowska, Human brain S100?? and S100?? mRNA expression increases with age: Pathogenic implications for Alzheimer's disease, Neurobiology of Aging, vol.17, issue.3, pp.359-363, 1996.
DOI : 10.1016/0197-4580(96)00037-1

E. R. Peskind, W. S. Griffin, K. T. Akama, M. A. Raskind, and L. J. Van-eldik, Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease, Neurochemistry International, vol.39, issue.5-6, pp.409-413, 2001.
DOI : 10.1016/S0197-0186(01)00048-1

A. Petzold, R. Jenkins, H. C. Watt, and A. J. Green, Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease, Neuroscience Letters, vol.336, issue.3, pp.167-170, 2003.
DOI : 10.1016/S0304-3940(02)01257-0

P. T. Nooijen, H. C. Schoonderwaldt, R. A. Wevers, O. R. Hommes, and K. J. Lamers, Neuron-Specific Enolase, S-100 Protein, Myelin Basic Protein and Lactate in CSF in Dementia, Dementia and Geriatric Cognitive Disorders, vol.8, issue.3, pp.169-173, 1997.
DOI : 10.1159/000106627

A. Jurewicz, M. Matysiak, C. S. Raine, and K. Selmaj, Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis, Neurology, vol.68, issue.4, pp.283-287, 2007.
DOI : 10.1212/01.wnl.0000252357.30287.1d

N. S. Schoonenboom, Y. A. Pijnenburg, C. Mulder, and S. M. Rosso, Amyloid ??(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease, Neurology, vol.62, issue.9, pp.1580-1584, 2004.
DOI : 10.1212/01.WNL.0000123249.58898.E0